$AVPT
AvePoint, Inc. Stock $avpt

$avpt Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000143774922007895 Filed on March 31, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$53.84M	$191.9M	$46.12M
YoY Change	16.73%	26.65%
Cost Of Revenue	$14.94M	$52.66M	$10.59M
YoY Change	41.06%	30.71%
Gross Profit	$38.89M	$139.2M	$35.53M
YoY Change	9.47%	25.17%
Gross Profit Margin	72.24%	72.56%	77.03%
Selling, General & Admin	$42.06M	$159.7M	$42.62M
YoY Change	-1.31%	40.84%
% of Gross Profit	108.14%	114.71%	119.96%
Research & Development	$4.132M	$31.77M	$3.440M
YoY Change	20.12%	160.28%
% of Gross Profit	10.62%	22.81%	9.68%
Depreciation & Amortization	$375.0K	$1.200M	$1.059M
YoY Change	-64.59%	9.09%
% of Gross Profit	0.96%	0.86%	2.98%
Operating Expenses	$46.57M	$192.7M	$46.32M
YoY Change	0.53%	52.14%
Operating Profit	-$7.672M	-$53.49M	-$10.79M
YoY Change	-28.92%	246.51%
Interest Expense	$1.422M	$102.0K	$1.115M
YoY Change	27.53%	148.78%
% of Operating Profit
Other Income/Expense, Net	$5.851M	-$632.0K	-$1.287M
YoY Change	-554.62%	23.68%
Pretax Income	-$399.0K	-$32.79M	-$10.97M
YoY Change	-96.36%	106.12%
Income Tax	$7.090M	$457.0K	$1.134M
% Of Pretax Income
Net Earnings	-$8.050M	-$35.22M	-$12.13M
YoY Change	-33.61%	107.22%
Net Earnings / Revenue	-14.95%	-18.35%	-26.29%
Basic Earnings Per Share		-$0.48
Diluted Earnings Per Share	-$43.24K	-$0.48	-$67.26K
COMMON SHARES
Basic Shares Outstanding	181.4M	141.6M
Diluted Shares Outstanding		141.6M

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$270.6M	$270.6M	$197.6K
YoY Change	136836.7%	286.04%
Cash & Equivalents	$268.2M	$268.2M	$69.11M
Short-Term Investments	$2.411M	$2.411M
Other Short-Term Assets	$8.461M	$8.461M	$552.1K
YoY Change	1432.57%	261.12%
Inventory
Prepaid Expenses
Receivables	$55.07M	$55.07M	$48.25M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$334.2M	$334.2M	$120.7M
YoY Change	176.86%	176.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.922M	$3.922M	$2.663M
YoY Change	47.28%	47.28%
Goodwill	$0.00
YoY Change
Intangibles	$0.00
YoY Change
Long-Term Investments			$351.9M
YoY Change
Other Assets	$11.73M	$44.39M	$8.252M
YoY Change	42.2%	13.4%
Total Long-Term Assets	$54.58M	$54.58M	$48.36M
YoY Change	12.87%	12.87%
TOTAL ASSETS
Total Short-Term Assets	$334.2M	$334.2M	$120.7M
Total Long-Term Assets	$54.58M	$54.58M	$48.36M
Total Assets	$388.7M	$388.7M	$169.1M
YoY Change	129.95%	129.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.824M	$1.824M	$774.0K
YoY Change	135.66%	135.66%
Accrued Expenses	$31.12M	$31.12M
YoY Change		27.9%
Deferred Revenue	$74.29M		$65.20M
YoY Change	13.94%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$111.2M	$111.2M	$92.22M
YoY Change	20.56%	20.56%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.943M	$21.99M	$3.658M
YoY Change	7.79%	-61.17%
Total Long-Term Liabilities	$3.943M	$21.99M	$3.658M
YoY Change	7.79%	-61.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$111.2M	$111.2M	$92.22M
Total Long-Term Liabilities	$3.943M	$21.99M	$3.658M
Total Liabilities	$133.2M	$138.4M	$148.9M
YoY Change	-10.54%	-8.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$375.3M		-$299.8M
YoY Change	25.19%
Common Stock	$18.00K		$12.00K
YoY Change	50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.739M		$0.00
YoY Change
Treasury Stock Shares
Shareholders Equity	$250.4M	$250.4M	-$192.8M
YoY Change
Total Liabilities & Shareholders Equity	$388.7M	$388.7M	$169.1M
YoY Change	129.95%	129.95%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$8.050M	-$35.22M	-$12.13M
YoY Change	-33.61%	107.22%
Depreciation, Depletion And Amortization	$375.0K	$1.200M	$1.059M
YoY Change	-64.59%	9.09%
Cash From Operating Activities	$8.995M	$5.030M	$21.21M
YoY Change	-57.59%	-73.69%
INVESTING ACTIVITIES
Capital Expenditures	$1.010M	$2.461M	$710.0K
YoY Change	42.25%	140.57%
Acquisitions		$0.00
YoY Change
Other Investing Activities	-$1.294M	-$3.377M	-$193.6K
YoY Change	568.42%	-346.86%
Cash From Investing Activities	-$1.294M	-$3.377M	-$193.6K
YoY Change	568.42%	-346.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$1.628M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.009M	$198.6M	35.56M
YoY Change	-97.16%	458.56%
NET CHANGE
Cash From Operating Activities	8.995M	$5.030M	21.21M
Cash From Investing Activities	-1.294M	-$3.377M	-193.6K
Cash From Financing Activities	1.009M	$198.6M	35.56M
Net Change In Cash	8.710M	$199.1M	56.57M
YoY Change	-84.6%	249.61%
FREE CASH FLOW
Cash From Operating Activities	$8.995M	$5.030M	$21.21M
Capital Expenditures	$1.010M	$2.461M	$710.0K
Free Cash Flow	$7.985M	$2.569M	$20.50M
YoY Change	-61.04%	-85.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12204000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11148000	USD
CY2021Q4	us-gaap	Assets Assets	388738000	USD
CY2020	dei	Auditor Location AuditorLocation	New York, New York
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	838000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1767000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	243360000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	181822000
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	181822000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100068000
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	100068000
CY2021Q3	avpt	Business Combination Share Exchange Ratio BusinessCombinationShareExchangeRatio	8.69144	pure
CY2020	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0	USD
CY2019	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0	USD
CY2020Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	191909000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	151533000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	116099000	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2021Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1
CY2021	us-gaap	Income Tax Reconciliation Repatriation Of Foreign Earnings IncomeTaxReconciliationRepatriationOfForeignEarnings	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	USD
CY2018	avpt	Payments For Unconditional Purchase Commitment PaymentsForUnconditionalPurchaseCommitment	0	USD
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	181821767
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	100068469
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	18400000	USD
CY2021	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	0	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	268217000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69112000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	2411000	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	992000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	55067000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	48250000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8461000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2343000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	334156000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	120697000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3922000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2663000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	38926000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	31943000	USD
CY2021Q4	avpt	Unbilled Receivables Noncurrent UnbilledReceivablesNoncurrent	6268000	USD
CY2020Q4	avpt	Unbilled Receivables Noncurrent UnbilledReceivablesNoncurrent	5499000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5466000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8252000	USD
CY2020Q4	us-gaap	Assets Assets	169054000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1824000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	774000	USD
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	35062000	USD
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	26245000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	74294000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	65203000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	111180000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	92222000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	8038000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9485000	USD
CY2021Q4	us-gaap	Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent	0	USD
CY2020Q4	us-gaap	Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent	43502000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	10012000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3943000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3658000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	133173000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	148867000	USD
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	5210000	USD
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	3061000	USD
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	5210000	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	213014000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	18000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	625056000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	105159000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1739000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	-0	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2317000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1791000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-375297000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-299789000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	250355000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-192827000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	388738000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	169054000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	191909000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	151533000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	116099000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	52664000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	40290000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	36399000	USD
CY2021	us-gaap	Gross Profit GrossProfit	139245000	USD
CY2020	us-gaap	Gross Profit GrossProfit	111243000	USD
CY2019	us-gaap	Gross Profit GrossProfit	79700000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	100512000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	76545000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	61901000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	59221000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36872000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24614000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31765000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1238000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1059000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-32788000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15907000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19560000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	457000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1062000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	614000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-33245000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-16969000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-20174000	USD
CY2021	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	1974000	USD
CY2020	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	27000	USD
CY2019	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-35219000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1049000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	192736000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	126680000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	98712000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-53491000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-15437000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-19012000	USD
CY2021	avpt	Gain Loss On Change In Contingent Liability And Warrants GainLossOnChangeInContingentLiabilityAndWarrants	21233000	USD
CY2020	avpt	Gain Loss On Change In Contingent Liability And Warrants GainLossOnChangeInContingentLiabilityAndWarrants	0	USD
CY2019	avpt	Gain Loss On Change In Contingent Liability And Warrants GainLossOnChangeInContingentLiabilityAndWarrants	0	USD
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	102000	USD
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	41000	USD
CY2019	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	56000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-632000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-511000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-604000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-16996000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-20174000	USD
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	32928000	USD
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	34446000	USD
CY2019	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	107469000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-68147000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-51442000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-127643000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.72
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.72
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	141596000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89638000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74006000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	141596000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89638000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74006000
CY2021	us-gaap	Profit Loss ProfitLoss	-33245000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-16969000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-20174000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	463000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	217000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	347000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	463000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	217000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	347000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-32782000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-16752000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-19827000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1911000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	27000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-0	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-34693000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16779000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19827000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-192827000	USD
CY2021	avpt	Reclassification Of Shared Based Awards To Temporary Equity ReclassificationOfSharedBasedAwardsToTemporaryEquity	-206000	USD
CY2021	avpt	Remeasurement Of Redemption Value Of Common Shares RemeasurementOfRedemptionValueOfCommonShares	-7361000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8242000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	46475000	USD
CY2021	avpt	Remeasurement Of Redemption Value Of Convertible Preferred Stock RemeasurementOfRedemptionValueOfConvertiblePreferredStock	-32928000	USD
CY2021	avpt	Issuance Of Redeemable Noncontrolling Interest Stockholders Equity Impact IssuanceOfRedeemableNoncontrollingInterestStockholdersEquityImpact	515000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	85393000	USD
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	299739000	USD
CY2021	avpt	Reclassifications Of Earn Out Rs Us To Earn Out Shares ReclassificationsOfEarnOutRSUsToEarnOutShares	714000	USD
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1739000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-33245000	USD
CY2021	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	1974000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	526000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	250355000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-198682000	USD
CY2020	avpt	Reclassification Of Shared Based Awards To Temporary Equity ReclassificationOfSharedBasedAwardsToTemporaryEquity	-198000	USD
CY2020	avpt	Remeasurement Of Redemption Value Of Common Shares RemeasurementOfRedemptionValueOfCommonShares	-14390000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	612000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3277000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	56261000	USD
CY2020	avpt	Settlement Of Restricted Stock Issued In Exchange For Nonrecourse Promissory Note Value SettlementOfRestrictedStockIssuedInExchangeForNonrecoursePromissoryNoteValue	4640000	USD
CY2020	avpt	Stock Issued During Period Value Issued For Issuance Cost StockIssuedDuringPeriodValueIssuedForIssuanceCost	2407000	USD
CY2020	avpt	Remeasurement Of Redemption Value Of Convertible Preferred Stock RemeasurementOfRedemptionValueOfConvertiblePreferredStock	-32976000	USD
CY2020	avpt	Equity Adjustment For Redemption Of Convertible Preferred Stock EquityAdjustmentForRedemptionOfConvertiblePreferredStock	-1470000	USD
CY2020	avpt	Issuance Of Redeemable Noncontrolling Interest Stockholders Equity Impact IssuanceOfRedeemableNoncontrollingInterestStockholdersEquityImpact	4471000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-16969000	USD
CY2020	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	27000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	217000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-192827000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-142809000	USD
CY2019	avpt	Reclassification Of Shared Based Awards To Temporary Equity ReclassificationOfSharedBasedAwardsToTemporaryEquity	-517000	USD
CY2019	avpt	Remeasurement Of Redemption Value Of Common Shares RemeasurementOfRedemptionValueOfCommonShares	-10684000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	88000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3094000	USD
CY2019	avpt	Reclassification Of Options From Permanent Equity To Liability ReclassificationOfOptionsFromPermanentEquityToLiability	-2203000	USD
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	33670000	USD
CY2019	avpt	Remeasurement Of Redemption Value Of Convertible Preferred Stock RemeasurementOfRedemptionValueOfConvertiblePreferredStock	-3013000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-20174000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	59508000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	33767000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	13893000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	15000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-80000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-7000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5914000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	347000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-198682000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-33245000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-16969000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-20174000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1238000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1059000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1049000	USD
CY2021	avpt	Foreign Currency Remeasurement Gain Loss ForeignCurrencyRemeasurementGainLoss	-1308000	USD
CY2020	avpt	Foreign Currency Remeasurement Gain Loss ForeignCurrencyRemeasurementGainLoss	378000	USD
CY2019	avpt	Foreign Currency Remeasurement Gain Loss ForeignCurrencyRemeasurementGainLoss	-362000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-740000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	690000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	296000	USD
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-175000	USD
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-433000	USD
CY2019	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1610000	USD
CY2021	avpt	Gain Loss On Change In Contingent Liability And Warrants GainLossOnChangeInContingentLiabilityAndWarrants	21233000	USD
CY2020	avpt	Gain Loss On Change In Contingent Liability And Warrants GainLossOnChangeInContingentLiabilityAndWarrants	-0	USD
CY2019	avpt	Gain Loss On Change In Contingent Liability And Warrants GainLossOnChangeInContingentLiabilityAndWarrants	-0	USD
CY2021	avpt	Increase Decrease In Accounts Receivable And Long Term Unbilled Receivables IncreaseDecreaseInAccountsReceivableAndLongTermUnbilledReceivables	9012000	USD
CY2020	avpt	Increase Decrease In Accounts Receivable And Long Term Unbilled Receivables IncreaseDecreaseInAccountsReceivableAndLongTermUnbilledReceivables	8946000	USD
CY2019	avpt	Increase Decrease In Accounts Receivable And Long Term Unbilled Receivables IncreaseDecreaseInAccountsReceivableAndLongTermUnbilledReceivables	13150000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1204000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-156000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	8121000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3236000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5023000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	10626000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	971000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7778000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	10805000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	11311000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	14365000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5030000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19120000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2051000	USD
CY2021	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	916000	USD
CY2020	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-2391000	USD
CY2019	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	398000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2461000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1023000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1083000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3377000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1368000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1481000	USD
CY2021	avpt	Proceeds From Recapitalization Gross ProceedsFromRecapitalizationGross	491563000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12162000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16378000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	268217000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	69112000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12162000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	13000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4037000	USD
CY2020	avpt	Proceeds From Recapitalization Gross ProceedsFromRecapitalizationGross	0	USD
CY2019	avpt	Proceeds From Recapitalization Gross ProceedsFromRecapitalizationGross	0	USD
CY2021	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	130925000	USD
CY2020	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	33712000	USD
CY2019	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	179000000	USD
CY2021	avpt	Payments For Redemption Of Legacy Common Stock PaymentsForRedemptionOfLegacyCommonStock	106169000	USD
CY2020	avpt	Payments For Redemption Of Legacy Common Stock PaymentsForRedemptionOfLegacyCommonStock	-0	USD
CY2019	avpt	Payments For Redemption Of Legacy Common Stock PaymentsForRedemptionOfLegacyCommonStock	-0	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1628000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	USD
CY2021	avpt	Payment Of Net Cash Settlement For Directive Outstanding Options PaymentOfNetCashSettlementForDirectiveOutstandingOptions	7530000	USD
CY2020	avpt	Payment Of Net Cash Settlement For Directive Outstanding Options PaymentOfNetCashSettlementForDirectiveOutstandingOptions	-0	USD
CY2019	avpt	Payment Of Net Cash Settlement For Directive Outstanding Options PaymentOfNetCashSettlementForDirectiveOutstandingOptions	-0	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5566000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	612000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	88000	USD
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	753000	USD
CY2020	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	7505000	USD
CY2019	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	25000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	49000	USD
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	82000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	300000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	USD
CY2021	avpt	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	0	USD
CY2020	avpt	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	58770000	USD
CY2019	avpt	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	33670000	USD
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	284000	USD
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2021	avpt	Proceeds From Nonrecourse Promissory Note ProceedsFromNonrecoursePromissoryNote	0	USD
CY2020	avpt	Proceeds From Nonrecourse Promissory Note ProceedsFromNonrecoursePromissoryNote	4639000	USD
CY2019	avpt	Proceeds From Nonrecourse Promissory Note ProceedsFromNonrecoursePromissoryNote	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	150000000	USD
CY2021	avpt	Payments For Transaction Fees Business Acquisition PaymentsForTransactionFeesBusinessAcquisition	2998000	USD
CY2020	avpt	Payments For Transaction Fees Business Acquisition PaymentsForTransactionFeesBusinessAcquisition	2089000	USD
CY2019	avpt	Payments For Transaction Fees Business Acquisition PaymentsForTransactionFeesBusinessAcquisition	-0	USD
CY2021	avpt	Proceeds From Recapitalization Issuance Costs ProceedsFromRecapitalizationIssuanceCosts	49990000	USD
CY2020	avpt	Proceeds From Recapitalization Issuance Costs ProceedsFromRecapitalizationIssuanceCosts	101000	USD
CY2019	avpt	Proceeds From Recapitalization Issuance Costs ProceedsFromRecapitalizationIssuanceCosts	4770000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	198617000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35559000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-94000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1165000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	903000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-590000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	199105000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	56950000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4216000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	69112000	USD
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><span style="text-decoration: underline; "><i><b>Comparative Data</b></i></span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">Certain amounts from prior periods which have been presented separately have been grouped to conform to the current period presentation, including:</p> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align: middle; width: 3%;"> </td><td style="vertical-align: top; width: 2%;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">•</p> </td><td style="vertical-align: top; width: 1%;"> </td><td style="vertical-align: top; width: 95%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The reclassification of prepaid rent to be included in prepaid expenses and other current assets on the consolidated balance sheets as of <em style="font: inherit;"> December 31, 2020;</em></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align: middle; width: 3%;"> </td><td style="vertical-align: top; width: 2%;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">•</p> </td><td style="vertical-align: top; width: 1%;"> </td><td style="vertical-align: top; width: 95%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The reclassification of accrued rent obligation to be included in accounts payable, accrued expenses and other liabilities on the consolidated statements of cash flows for the years ended <em style="font: inherit;"> December 31, 2020 </em>and <em style="font: inherit;">2019;</em></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align: middle; width: 3%;"> </td><td style="vertical-align: top; width: 2%;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">•</p> </td><td style="vertical-align: top; width: 1%;"> </td><td style="vertical-align: top; width: 95%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The reclassification of equity issuance costs to be offset from proceeds from issuance of common stock on the consolidated statements of mezzanine equity and stockholders' equity (deficiency) for the year ended <em style="font: inherit;"> December 31, 2020;</em></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align: middle; width: 3%;"> </td><td style="vertical-align: top; width: 2%;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">•</p> </td><td style="vertical-align: top; width: 1%;"> </td><td style="vertical-align: top; width: 95%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The reclassification of equity issuance costs to be offset from proceeds from issuance of Series C preferred stock on the consolidated statements of mezzanine equity and stockholders' equity (deficiency) for the year ended <em style="font: inherit;"> December 31, 2019;</em></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align: middle; width: 3%;"> </td><td style="vertical-align: top; width: 2%;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">•</p> </td><td style="vertical-align: top; width: 1%;"> </td><td style="vertical-align: top; width: 95%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The reclassification of remeasurement of redemption value of Series B preferred stock to be offset from remeasurement of redemption value of Series C preferred stock and both included in the remeasurement of redemption value of convertible preferred stock on the consolidated statements of mezzanine equity and stockholders’ equity (deficiency) for the year ended <em style="font: inherit;"> December 31, 2019; </em>and</p> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align: middle; width: 3%;"> </td><td style="vertical-align: top; width: 2%;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">•</p> </td><td style="vertical-align: top; width: 1%;"> </td><td style="vertical-align: top; width: 95%;">The reclassification of current portion of capital lease and deferred rent into others on the Note <em style="font: inherit;">7</em> — accrued expenses and other liabilities in the notes to consolidated financial statements as of <em style="font: inherit;"> December 31, 2020.</em></td></tr> </tbody></table>
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1068000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	247000	USD
CY2021	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2020	us-gaap	Stock Issued1 StockIssued1	2408000	USD
CY2019	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	29000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	57000	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><em style="font: inherit;">1.</em> Nature of Business and Organization </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Apex Technology Acquisition Corporation ("<i><b>Apex</b></i>") was a blank check company incorporated in Delaware on <em style="font: inherit;"> April 5, 2019. </em>Apex was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with <em style="font: inherit;">one</em> or more businesses. AvePoint, Inc. (“<i><b>Legacy AvePoint</b></i>”) was incorporated as a New Jersey corporation on <em style="font: inherit;"> July </em><em style="font: inherit;">24,</em> <em style="font: inherit;">2001,</em> was redomiciled as a Delaware corporation in <em style="font: inherit;">2006,</em> and changed its name to "AvePoint Operations, Inc." in <em style="font: inherit;"> June </em><em style="font: inherit;">2021.</em></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">On <em style="font: inherit;"> November </em><em style="font: inherit;">23,</em> <em style="font: inherit;">2020,</em> Legacy AvePoint and the members of the Apex Group entered into the Business Combination Agreement. On <em style="font: inherit;"> July 1, 2021, </em>Pursuant to the terms of the Business Combination Agreement, Merger Sub <em style="font: inherit;">1,</em> a wholly owned subsidiary of Apex, merged with and into Legacy AvePoint, with Legacy AvePoint surviving the merger as a wholly-owned subsidiary of Apex. Promptly following the <em style="font: inherit;">first</em> merger, Legacy AvePoint merged with and into Merger Sub <em style="font: inherit;">2,</em> with Merger Sub <em style="font: inherit;">2</em> as the surviving company and a wholly owned subsidiary of Apex, subsequently renamed “AvePoint US LLC.” Following the consummation of those merger activities, Apex was renamed “AvePoint, Inc.” On <em style="font: inherit;"> July 26, 2021, </em>AvePoint US LLC merged with and into AvePoint, Inc. with AvePoint, Inc. (hereinafter referred to as “<i><b>AvePoint</b></i>,” “<i><b>we</b></i>,” "<i><b>us</b></i>," or “<i><b>our</b></i>”) surviving. See the sections of this Annual Report titled "<i>Business </i>—<i> <em style="font: inherit;">2021</em> Consummation of the Business Combination</i>” (Part I, Item <em style="font: inherit;">1</em> of this Annual Report) and "<i>Note <em style="font: inherit;">3</em> - Business Combination</i>" (Part II, Item <em style="font: inherit;">8</em> of this Annual Report) for additional information.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-indent: 36pt; text-align: justify;">We are a leading provider of enterprise collaboration and productivity software solutions. We develop, market, and sell our suite of software solutions and services, primarily in North America, Europe, Australia, and Asia. We provide our customers with high-performance infrastructure management, compliance, data governance, mobility and productivity, online services and software solutions consulting. We do this through our Confidence Platform, a SaaS platform that assists organizations who use <em style="font: inherit;">M365</em> and more than a half dozen other cloud collaboration utilities. Our Confidence Platform, built on AOS, contains our suites of software solutions: our Control Suite, for data governance enabling collaboration services at scale, with automation and repeatable business templates; our Fidelity Suite for the preservation of data integrity as organizations undergo digital transformation projects to streamline the way they work from <em style="font: inherit;">one</em> collaboration system to the next; and our Resilience Suite to help organizations comply with data governance regulations, preserve business records for compliance, and ensure business continuity.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Our principal headquarters are located in Jersey City, New Jersey, with our operating headquarters in Richmond, Virginia and additional offices in North America, Europe, Asia, Australia and the Middle East.</p>
CY2021Q3	avpt	Business Combination Share Exchange Ratio BusinessCombinationShareExchangeRatio	8.69144	pure
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><span style="text-decoration: underline; "><i><b>Use of Estimates </b></i></span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. We base our estimates and assumptions on historical experience and on various other assumptions that we believe are reasonable under the circumstances. The amounts of assets and liabilities reported in our consolidated balance sheets and the amounts of revenue and expenses reported for each of its periods presented are affected by estimates and assumptions, which are used for, but <em style="font: inherit;">not</em> limited to, the accounting for revenue recognition, allowance for doubtful accounts, deferred contract costs, income taxes and related reserves, stock-based compensation, and earn-out liabilities. Actual results and outcomes <em style="font: inherit;"> may </em>differ from management’s estimates and assumptions due to risks and uncertainties, including uncertainty in the current economic environment due to the outbreak of COVID-<em style="font: inherit;">19.</em></p>
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	38900000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	31900000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-51442000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1000000.0	USD
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	9500000	USD
CY2020	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	10500000	USD
CY2019	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	7700000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	74700000	USD
CY2021Q4	us-gaap	Cash Cash	9300000	USD
CY2020Q4	us-gaap	Cash Cash	6800000	USD
CY2021	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0	USD
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	62100000	USD
CY2019Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	43619000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	60600000	USD
CY2019Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	28351000	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	53749000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	74688000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	31943000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10130000	USD
CY2020	avpt	Deferred Revenue Increase Decrease DeferredRevenueIncreaseDecrease	14088000	USD
CY2020	avpt	Increase Decrease In Capitalized Contract Costs Net IncreaseDecreaseInCapitalizedContractCostsNet	3592000	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	53749000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	74688000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	31943000	USD
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	61335000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	82332000	USD
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	38926000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7586000	USD
CY2021	avpt	Deferred Revenue Increase Decrease DeferredRevenueIncreaseDecrease	7644000	USD
CY2021	avpt	Increase Decrease In Capitalized Contract Costs Net IncreaseDecreaseInCapitalizedContractCostsNet	6983000	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.76	pure
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1100000	USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	avpt	Payments For Exchange Of Common Stock In Business Combination PaymentsForExchangeOfCommonStockInBusinessCombination	106200000	USD
CY2021Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	10602105
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	180272638
CY2021Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	17905000
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q3	us-gaap	Cash Acquired In Excess Of Payments To Acquire Business CashAcquiredInExcessOfPaymentsToAcquireBusiness	204500000	USD
CY2021Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	56200000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	838000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1767000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	55067000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	48250000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11206000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8945000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7284000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6282000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3922000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2663000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1200000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	22740000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	16738000	USD
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	3945000	USD
CY2020Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2571000	USD
CY2021Q4	avpt	Cloud Service Fees Current CloudServiceFeesCurrent	1314000	USD
CY2020Q4	avpt	Cloud Service Fees Current CloudServiceFeesCurrent	994000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1033000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	500000	USD
CY2021Q4	avpt	Accrued Partner Expenses Current AccruedPartnerExpensesCurrent	903000	USD
CY2020Q4	avpt	Accrued Partner Expenses Current AccruedPartnerExpensesCurrent	1253000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1197000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1713000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3930000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2476000	USD
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	35062000	USD
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	26245000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-23583000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-19107000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-13320000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-9205000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3200000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-6240000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-32788000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15907000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19560000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	467000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-881000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	411000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	80000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1117000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1096000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1813000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	703000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1507000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1893000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	89000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-175000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-12000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-843000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-323000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	573000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1279000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-246000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-445000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1279000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	457000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1062000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	614000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6886000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3340000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4108000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-962000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-519000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	80000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	10865000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	6770000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2748000	USD
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-375000	USD
CY2021	avpt	Effective Income Tax Rate Reconciliation Returntoprovision Adjustments Amount EffectiveIncomeTaxRateReconciliationReturntoprovisionAdjustmentsAmount	-196000	USD
CY2020	avpt	Effective Income Tax Rate Reconciliation Returntoprovision Adjustments Amount EffectiveIncomeTaxRateReconciliationReturntoprovisionAdjustmentsAmount	-538000	USD
CY2019	avpt	Effective Income Tax Rate Reconciliation Returntoprovision Adjustments Amount EffectiveIncomeTaxRateReconciliationReturntoprovisionAdjustmentsAmount	497000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	334000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	65000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	157000	USD
CY2021	avpt	Effective Income Tax Rate Reconciliation Fair Value Of Earnout Liability Amount EffectiveIncomeTaxRateReconciliationFairValueOfEarnoutLiabilityAmount	-3946000	USD
CY2020	avpt	Effective Income Tax Rate Reconciliation Fair Value Of Earnout Liability Amount EffectiveIncomeTaxRateReconciliationFairValueOfEarnoutLiabilityAmount	0	USD
CY2019	avpt	Effective Income Tax Rate Reconciliation Fair Value Of Earnout Liability Amount EffectiveIncomeTaxRateReconciliationFairValueOfEarnoutLiabilityAmount	0	USD
CY2021	avpt	Effective Income Tax Rate Reconciliation Transaction Costs Amount EffectiveIncomeTaxRateReconciliationTransactionCostsAmount	-2209000	USD
CY2020	avpt	Effective Income Tax Rate Reconciliation Transaction Costs Amount EffectiveIncomeTaxRateReconciliationTransactionCostsAmount	0	USD
CY2019	avpt	Effective Income Tax Rate Reconciliation Transaction Costs Amount EffectiveIncomeTaxRateReconciliationTransactionCostsAmount	0	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3085000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-3216000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1516000	USD
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	440000	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1575000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-68000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	265000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	99000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	457000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1062000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	614000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10716000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6814000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	5315000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	4886000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	4384000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1792000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	720000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	720000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	181000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1047000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1066000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	22363000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15278000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	132000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	140000	USD
CY2021Q4	avpt	Deferred Tax Liabilities Amortization DeferredTaxLiabilitiesAmortization	214000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5530000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2738000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2111000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8400000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5500000	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2900000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-4600000	USD
CY2020Q4	avpt	Deferred Tax Liabilities Amortization DeferredTaxLiabilitiesAmortization	-0	USD
CY2021Q4	avpt	Deferred Tax Liabilities Commissions DeferredTaxLiabilitiesCommissions	7918000	USD
CY2020Q4	avpt	Deferred Tax Liabilities Commissions DeferredTaxLiabilitiesCommissions	5285000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	822000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	580000	USD
CY2021Q4	avpt	Deferred Tax Liabilities Unbilled Receivable DeferredTaxLiabilitiesUnbilledReceivable	2183000	USD
CY2020Q4	avpt	Deferred Tax Liabilities Unbilled Receivable DeferredTaxLiabilitiesUnbilledReceivable	1632000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	11269000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	7637000	USD
CY2021Q4	avpt	Deferred Tax Assets Gross Net Of Liabilities DeferredTaxAssetsGrossNetOfLiabilities	11094000	USD
CY2020Q4	avpt	Deferred Tax Assets Gross Net Of Liabilities DeferredTaxAssetsGrossNetOfLiabilities	7641000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8356000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5369000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5230000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	139000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	4281000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	-0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1088000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5369000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1300000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1200000	USD
CY2021	avpt	Unrecognized Tax Benefits Decrease Resulting From Filing Amended Tax Returns UnrecognizedTaxBenefitsDecreaseResultingFromFilingAmendedTaxReturns	4000000.0	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	6400000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	5600000	USD
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	5400000	USD
CY2021Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On First Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary	6813000	USD
CY2021Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	29600000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	5680000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3808000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2428000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1840000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1438000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2960000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	18154000	USD
CY2017Q2	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	8000000.0	USD
CY2019	avpt	Payments For Unconditional Purchase Commitment PaymentsForUnconditionalPurchaseCommitment	5500000	USD
CY2020	avpt	Payments For Unconditional Purchase Commitment PaymentsForUnconditionalPurchaseCommitment	3800000	USD
CY2021Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary	0	USD
CY2021Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Third Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary	0	USD
CY2021Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Fourth Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary	0	USD
CY2021Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Fifth Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary	0	USD
CY2021Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Due After Five Years UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears	0	USD
CY2021Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	6813000	USD
CY2021Q3	avpt	Number Of Shares Exchangeable At1250 NumberOfSharesExchangeableAt1250	1000000
CY2021Q3	avpt	Number Of Shares Exchangeable At1500 NumberOfSharesExchangeableAt1500	1000000
CY2021Q3	avpt	Number Of Shares Exchangeable At1750 NumberOfSharesExchangeableAt1750	1000000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	10000000.0	USD
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	20300000	USD
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	181821767
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100068469
CY2021Q3	avpt	Business Combination Share Exchange Ratio BusinessCombinationShareExchangeRatio	8.69144	pure
CY2021Q3	avpt	Number Of Shares Subject To Vesting Provision NumberOfSharesSubjectToVestingProvision	2916700
CY2021	avpt	Number Of Shares Subject To Vesting Provision NumberOfSharesSubjectToVestingProvision	0
CY2020Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	403400000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	USD
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	10000000.0	SDG
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	7500000	USD
CY2021Q1	avpt	Redeemable Noncontrolling Interest Increase From Contribution By Noncontrolling Interest RedeemableNoncontrollingInterestIncreaseFromContributionByNoncontrollingInterest	1000000.0	SGD
CY2021Q1	avpt	Redeemable Noncontrolling Interest Increase From Contribution By Noncontrolling Interest RedeemableNoncontrollingInterestIncreaseFromContributionByNoncontrollingInterest	800000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	23326692
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.96
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M13D
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5333452
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.52
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	451953
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.19
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	2501900
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.70
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	24926640
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.13
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y5M1D
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	11537242
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.91
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	707888
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.77
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	898926
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.32
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	34857068
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.05
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M20D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5611658
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.64
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5141331
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.08
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	4847078
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.44
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	30480317
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	0	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.87
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y9M29D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	92600000	USD
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	30480317
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y3M29D
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	3.87
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	15375845
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y10M6D
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	1.99
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	42700000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	30480317
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	15375845
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	92600000	USD
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	66100000	USD
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5141331
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	40000000.0	USD
CY2019Q4	avpt	Put Option Redemption Share PutOptionRedemptionShare	3113170
CY2019Q4	avpt	Put Option Underlying Option PutOptionUnderlyingOption	5148777
CY2021Q3	avpt	Liability Balance Related To Common Stock LiabilityBalanceRelatedToCommonStock	49700000	USD
CY2020Q4	avpt	Liability Balance Related To Common Stock LiabilityBalanceRelatedToCommonStock	6700000	USD
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	0	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	191909000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	151533000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	116099000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3922000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2663000	USD
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2021	us-gaap	Profit Loss ProfitLoss	-33245000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-16969000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-20174000	USD
CY2020	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	27000	USD
CY2021	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	1974000	USD
CY2019	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-35219000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-16996000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-20174000	USD
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	32928000	USD
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	34446000	USD
CY2019	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	107469000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-68147000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-127643000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	141596000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89638000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74006000
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2019	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	141596000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89638000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74006000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.72
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.72
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	56552000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	76858000
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	78625000

Files In Submission

Name	View Source	Status
0001437749-22-007895-index-headers.html	Edgar Link	pending
0001437749-22-007895-index.html	Edgar Link	pending
0001437749-22-007895.txt	Edgar Link	pending
0001437749-22-007895-xbrl.zip	Edgar Link	pending
a01.jpg	Edgar Link	pending
a02.jpg	Edgar Link	pending
a03.jpg	Edgar Link	pending
a04.jpg	Edgar Link	pending
a07.jpg	Edgar Link	pending
a10.jpg	Edgar Link	pending
a11.jpg	Edgar Link	pending
a12.jpg	Edgar Link	pending
a13.jpg	Edgar Link	pending
aos.jpg	Edgar Link	pending
avpt-20211231.xsd	Edgar Link	pending
avpt-20211231_cal.xml	Edgar Link	unprocessable
avpt-20211231_def.xml	Edgar Link	unprocessable
avpt-20211231_lab.xml	Edgar Link	unprocessable
avpt-20211231_pre.xml	Edgar Link	unprocessable
avpt20211231_10k.htm	Edgar Link	pending
avpt20211231_10k_htm.xml	Edgar Link	completed
backandfrontofficev1.jpg	Edgar Link	pending
bestplacetowork2022chicago.jpg	Edgar Link	pending
bestplacetowork2022nyc.jpg	Edgar Link	pending
cloudgovernance.jpg	Edgar Link	pending
cloudmanagement.jpg	Edgar Link	pending
complianceguardian.jpg	Edgar Link	pending
confidenceplatform.jpg	Edgar Link	pending
customerlogotable.jpg	Edgar Link	pending
docave.jpg	Edgar Link	pending
edutech.jpg	Edgar Link	pending
ex_317332.htm	Edgar Link	pending
ex_317333.htm	Edgar Link	pending
ex_317334.htm	Edgar Link	pending
ex_317335.htm	Edgar Link	pending
ex_350344.htm	Edgar Link	pending
ex_350349.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
governanceautomation.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
myhub.jpg	Edgar Link	pending
njbest2021.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vabest2021.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVPT
AvePoint, Inc. Stock $avpt

2021 Q4 Form 10-K Financial Statement

#000143774922007895 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVPT AvePoint, Inc. Stock $avpt

2021 Q4 Form 10-K Financial Statement

#000143774922007895 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVPT
AvePoint, Inc. Stock $avpt